Patent 11987623 was granted and assigned to Novaliq on May, 2024 by the United States Patent and Trademark Office.
The invention provides novel compositions of antibodies based on liquid vehicles selected from semifluorinated alkanes. The use of these vehicles provides for improved stability and shelf-life of antibodies and their derivatives. The compositions are useful for topical administration or for parenteral injection.